Qualified Participants Must:
• Be patients with type II diabetes mellitus for at least 3 months before the screening visit
•
Be on diet/exercise and/or treatment with metformin (stable dose of more or equal to 1500 mg/day or maximal tolerated dose) for at least 3 months prior to screnning
Qualified Participants May Receive:
All study-related visits, tests and treatements will be provided at no cost. In addition, compensation of study-related time and travel may be provided.